Neurodegenerative changes of retina in Parkinson disease
https://doi.org/10.30629/2658-7947-2021-26-6-29-34
Abstract
In Parkinson’s disease (PD), some structural changes in the retina have been shown using optical coherence tomography (OCT). Among them most attractive are atrophic changes in retinal nerve fi ber layer (RNFL). However, diagnostic signifi cance of the OCT method in PD remains debatable.
Objective: to investigate a thickness of RNFL in Parkinson’s disease patients and to determine the signifi cance of the OCT method in the PD diagnostics.
Materials and methods. In PD patients (n = 24) and in a control group (n = 20) OCT was used to study the thickness of RNFL — average, in quadrants and in 10 sectors.
Results. In patients with PD thinning of RNFL in the inferior quadrant was revealed (p = 0.009). The sensitivity and specifi city of the method were 56% and 82%, respectively. The thickness of RNFL was not associated with parkinsonian symptoms asymmetry, duration and severity of the disease. In the control group and in PD patients, there was a relationship between the RNFL thickness and age.
Conclusion. PD is characterized by atrophic changes in the retina in the form of thinning of RNFL in the inferior quadrant, which confi rms the systemic nature of neurodegenerative pathology in this disease going beyond the substantia nigra and brain tissue. At the same time, the thickness of RNFL showed limited diagnostic value for detecting PD cases.
About the Authors
E. Yu. Fedotova
Research Center of Neurology
Russian Federation
Russian Federation
Moscow
N. V. Polkina
Research Center of Neurology
Russian Federation
Russian Federation
Moscow
E. N. Mikhailova
Research Center of Neurology
Russian Federation
Russian Federation
Moscow
S. N. Illarioshkin
Research Center of Neurology
Russian Federation
Russian Federation
Moscow
References
1. Nguyen-Legros J. Functional neuroarchitecture of the retina: hypothesis on the dysfunction of retinal dopaminergic circuitry in Parkinson’s disease. Surg Radiol Anat. 1988;10(2):137–144. https://doi.org/10.1007/BF02307822
2. Bodis-Wollner I., Kozlowski P.B., Glazman S., Miri S. α-synuclein in the inner retina in parkinson disease. Ann Neurol. 2014;75(6):964–966. https://doi.org/10.1002/ana.24182
3. Beach T.G., Carew J., Serrano G., Adler C.H., Shill H.A., Sue L.I., Sabbagh M.N., Akiyama H., Cuenca N. Arizona Parkinson’s Disease Consortium. Phosphorylated α-synuclein-immunoreactive retinal neuronal elements in Parkinson’s disease subjects. Neurosci Lett. 2014;571:34–38. https://doi.org/10.1016/j.neulet.2014.04.027
4. Devos D., Tir M., Maurage C.A., Waucquier N., Defebvre L., Defoort-Dhellemmes S., Destée A. ERG and anatomical abnormalities suggesting retinopathy in dementia with Lewy bodies. Neurology. 2005;65(7):1107–1110. https://doi.org/10.1212/01. wnl.0000178896.44905.33
5. Litvinenko I.V., Boyko E.V., Kulikov A.N., Dynin P.S., Trufanov A.G., Maltsev D.S., Yurin A.A. The relationship between visuospatial disorders in Parkinson’s disease and thickness of retina and cortex. Annals of Clinical and Experimental Neurology. 2016;10(2):11–16. (Russian). https://doi.org/10.17816/ psaic66
6. Doustar J., Torbati T., Black K.L., Koronyo Y., KoronyoHamaoui M. Optical Coherence Tomography in Alzheimer’s Disease and Other Neurodegenerative Diseases. Front Neurol. 2017;8:701. https://doi.org/10.3389/fneur.2017.00701
7. Inzelberg R., Ramirez J.A., Nisipeanu P., Ophir A. Retinal nerve fi ber layer thinning in Parkinson disease. Vision Res. 2004;44(24):2793–2797. https://doi.org/10.1016/j. visres.2004.06.009
8. Polo V., Satue M., Rodrigo M.J., Otin S., Alarcia R.., Bambo MP., Fuertes M.I., Larrosa J.M., Pablo L.E., Garcia-Martin E. Visual dysfunction and its correlation with retinal changes in patients with Parkinson’s disease: an observational cross-sectional study. BMJ Open. 2016;6(5):e009658. https://doi.org/10.1136/bmjopen-2015-009658
9. Miri S., Glazman S., Mylin L., Bodis-Wollner I. A combination of retinal morphology and visual electrophysiology testing increases diagnostic yield in Parkinson’s disease. Parkinsonism Relat Disord. 2016;S1:S134 — 137. https://doi.org/10.1016/j. parkreldis.2015.09.015
10. Slotnick S., Ding Y., Glazman S., Durbin M., Miri S., Selesnick I., Sherman J., Bodis-Wollner I. A novel retinal biomarker for Parkinson’s disease: Quantifying the foveal pit with optical coherence tomography. Mov Disord. 2015;30(12):1692–1695. https://doi.org/10.1002/mds.26411
11. Schneider M., Müller H.P., Lauda F., Tumani H., Ludolph A.C., Kassubek J., Pinkhardt E.H. Retinal single-layer analysis in Parkinsonian syndromes: an optical coherence tomography study. J Neural Transm (Vienna). 2014;121(1):41–47. https://doi. org/10.1007/s00702-013-1072-3
12. Roth N.M., Saidha S., Zimmermann H., Brandt AU., Isensee J., Benkhellouf-Rutkowska A., Dornauer M., Kühn A.A.., Müller T., Calabresi P.A., Paul F. Photoreceptor layer thinning in idiopathic Parkinson’s disease. Mov Disord. 2014;29(9):1163–1170. https:// doi.org/10.1002/mds.25896
13. Hughes A.J., Daniel S.E., Kilford L., Lees A.J. Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinicopathological study of 100 cases. J Neurol Neurosurg Psychiatry. 1992;55(3):181–184. https://doi.org/10.1136/jnnp.55.3.181
14. Yu J.G., Feng Y.F., Xiang Y., Huang J.H., Savini G., Parisi V., Yang W.J., Fu X.A. Retinal nerve fi ber layer thickness changes in Parkinson disease: a meta-analysis. PLoS One. 2014;9(1):e85718. https://doi.org/10.1371/journal.pone.0085718
15. Chrysou A., Jansonius N.M., van Laar T. Retinal layers in Parkinson’s disease: A meta-analysis of spectral-domain optical coherence tomography studies. Parkinsonism Relat Disord. 2019;64:40–49. https://doi.org/10.1016/j.parkreldis.2019.04.023
16. Huang L., Wang C., Wang W., Wang Y., Zhang R. The specifi c pattern of retinal nerve fi ber layer thinning in Parkinson’s disease: a systematic review and meta-analysis. J Neurol. 2021;268(11):4023-4032. https://doi.org/10.1007/s00415-020- 10094-0
17. Archibald N.K., Clarke M.P., Mosimann U.P., Burn D.J. Retinal thickness in Parkinson’s disease. Parkinsonism Relat Disord. 2011;17(6):431–436. https://doi.org/10.1016/j.parkreldis.2011.03.004
18. Cubo E., López Peña M.J., Diez-Feijo Varela E., Pérez Gil O., Garcia Gutierrez P., Araus González E., Prieto Tedejo R., Mariscal Pérez N., Armesto D. Lack of association of morphologic and functional retinal changes with motor and non-motor symptoms severity in Parkinson’s disease. J Neural Transm (Vienna). 2014;121(2):139–145. https://doi.org/10.1007/s00702-013- 1093-y
19. Mailankody P., Battu R., Khanna A., Lenka A., Yadav R., Pal P.K. Optical coherence tomography as a tool to evaluate retinal changes in Parkinson’s disease. Parkinsonism Relat Disord. 2015;21(10):1164–1169. https://doi.org/10.1016/j.parkreldis.2015.08.002
20. Nowacka B., Lubiński W., Honczarenko K., Potemkowski A., Safranow K. Bioelectrical function and structural assessment of the retina in patients with early stages of Parkinson’s disease (PD). Doc Ophthalmol. 2015;131(2):95–104. https://doi. org/10.1007/s10633-015-9503-0
21. La Morgia C., Barboni P., Rizzo G., Carbonelli M., Savini G., Scaglione C., Capellari S., Bonazza S., Giannoccaro M.P., CalandraBuonaura G., Liguori R., Cortelli P., Martinelli P., Baruzzi A., Carelli V. Loss of temporal retinal nerve fi bers in Parkinson disease: a mitochondrial pattern? Eur J Neurol. 2013;20(1):198– 201. https://doi.org/10.1111/j.1468-1331.2012.03701.x
22. Matlach J., Wagner M., Malzahn U., Schmidtmann I., Steigerwald F., Musacchio T., Volkmann J., Grehn F., Göbel W., Klebe S. Retinal changes in Parkinson’s disease and glaucoma. Parkinsonism Relat Disord. 2018;56:41–46. https://doi.org/10.1016/j. parkreldis.2018.06.016
23. Ferro Desideri L., Barra F., Ferrero S. Systemic and intraocular factors related to retinal thicknesses variations in patients with Parkinson’s disease. Parkinsonism Relat Disord. 2019;61:234– 235. https://doi.org/10.1016/j.parkreldis.2018.11.004
24. Jiménez B., Ascaso F.J., Cristóbal J.A., López del Val J. Development of a prediction formula of Parkinson disease severity by optical coherence tomography. Mov Disord. 2014;29(1):68–74. https://doi.org/10.1002/mds.25747
25. Garcia-Martin E., Rodriguez-Mena D., Satue M., Almarcegui C., Dolz I., Alarcia R., Seral M., Polo V., Larrosa J.M., Pablo L.E. Electrophysiology and optical coherence tomography to evaluate Parkinson disease severity. Invest Ophthalmol Vis Sci. 2014;55(2):696–705. https://doi.org/10.1167/iovs.13-13062
26. Ma L.J., Xu L.L., Mao C.J., Fu Y.T., Ji X.Y., Shen Y., Chen J., Yang Y.P., Liu C.F. Progressive Changes in the Retinal Structure of Patients with Parkinson’s Disease. J Parkinsons Dis. 2018;8(1):85–92. https://doi.org/10.3233/JPD-171184
27. Rascunà C., Cicero C.E., Chisari C.G., Russo A., Giuliano L., Castellino N., Terravecchia C., Grillo M., Longo A., Avitabile T., Zappia M., Reibaldi M., Nicoletti A. Retinal thickness and microvascular pathway in Idiopathic Rapid eye movement sleep behaviour disorder and Parkinson’s disease. Parkinsonism Relat Disord. 2021;88:40–45. https://doi.org/10.1016/j.parkreldis.2021.05.031
Review
For citations:
Fedotova E.Yu., Polkina N.V., Mikhailova E.N., Illarioshkin S.N. Neurodegenerative changes of retina in Parkinson disease. Russian neurological journal. 2021;26(6):29-34. (In Russ.) https://doi.org/10.30629/2658-7947-2021-26-6-29-34
Views:
548
Email this article 